In the pharmaceutical discovery process, understanding a drug’s residence time—the duration a molecule remains bound to its ...

Large language models are powering a new generation of AI agents that could transform computational chemistry from a ...

Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...

For more than 50 years, scientists have sought alternatives to silicon for building molecular electronics. The vision was ...

Boston Dynamics product lead Aya Durbin discusses Atlas, industrial humanoid robots, and what it takes to make humanoids ...

See how Langraph powers a multi-agent stock sim with configurable rounds and models, helping you compare trade plans without ...

Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...

By analyzing the archival data from the Atacama Large Millimeter/submillimeter Array (ALMA), an international team of ...

Boston Dynamics, a leader in mobile robotics, is largely owned by Hyundai, which bought 80% of the company in 2021. To invest in Boston Dynamics indirectly, consider buying Hyundai stock or ...

Artificial intelligence (AI) is revolutionising the field of drug discovery and disease modelling, with a significant impact ...